Technology / Scientific & Technical InstrumentsNYSE
$330.00
-8.33 (-2.46%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 22% · confianza 25%
FCF escenarios
weak_data · normalized FCF $1.2B · quality 81.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
53/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$56.3B
P/E
53.2x
↑EV/EBITDA
39.9x
↑ROE
14.5%
↑Gross Margin
62.1%
↑Debt/Equity
0.47
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2013–2025 · 12 años de histórico normalizado
Revenue CAGR
+5.3%
FCF CAGR
+8.2%
FCF margin
23.8%
FCF / Net income
1.51x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $5.38B · net income $850.0M · FCF $1.28B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | $5.38B | $5.38B | $4.98B | $5.46B | $5.42B | $4.94B | $4.22B | $4.30B | — | $3.19B | $2.92B | $2.86B | $2.93B | $2.89B |
| Net Income | $850.0M | $850.0M | $614.0M | $1.06B | $1.12B | $894.0M | $627.0M | $621.0M | $165.0M | $102.0M | $335.0M | $513.0M | $392.0M | $457.0M |
| EBITDA | $1.45B | $1.45B | $1.22B | $1.65B | $1.59B | — | — | — | — | $373.0M | $540.0M | $530.0M | $553.0M | $573.0M |
| EPS | 4.89 | 4.89 | 3.51 | 5.91 | 6.18 | 4.78 | 3.31 | 3.25 | 0.86 | 0.56 | 1.95 | 3.00 | 2.35 | 2.74 |
| Gross Margin | 62.1% | 62.1% | 62.9% | 64.6% | 63.7% | — | — | — | — | — | — | — | — | — |
| Operating Margin | 16.3% | 16.3% | 16.7% | 24.9% | 24.6% | 21.9% | 18.1% | 16.5% | — | 4.6% | 13.9% | 15.1% | 16.0% | 17.2% |
| Net Margin | 15.8% | 15.8% | 12.3% | 19.3% | 20.7% | 18.1% | 14.9% | 14.4% | — | 3.2% | 11.5% | 18.0% | 13.4% | 15.8% |
| Balance Sheet | ||||||||||||||
| Debt/Equity | 0.47 | 0.47 | 0.40 | 0.44 | 0.48 | 0.47 | 0.54 | 0.60 | 0.53 | 0.88 | 0.72 | 0.84 | 1.43 | — |
| Current Ratio | 1.90 | 1.90 | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||
| Free Cash Flow | $1.28B | $1.28B | $898.0M | $1.21B | $959.0M | $1.15B | $899.0M | $878.0M | $423.0M | $256.0M | $329.0M | $284.0M | $493.0M | $497.0M |
| Returns | ||||||||||||||
| ROE | 14.5% | 14.5% | 12.0% | 22.7% | 27.0% | 23.6% | 19.0% | 20.7% | 6.8% | 4.4% | 22.1% | 39.4% | 51.0% | — |
| Valuation | ||||||||||||||
| P/E | 53.23 | 53.23 | 43.18 | 21.28 | 26.51 | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 39.89 | 39.89 | 21.95 | 13.40 | 18.78 | — | — | — | — | — | — | — | — | — |
| P/B | 9.71 | 9.71 | 5.20 | 4.84 | 7.17 | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||
| Revenue Growth | 8.0% | 8.0% | -8.9% | 0.8% | — | 17.1% | -1.9% | — | — | 9.3% | 2.2% | -2.6% | 1.6% | — |
| EPS Growth | 39.3% | 39.3% | -40.6% | -4.4% | — | 44.4% | 1.8% | 277.9% | 53.6% | -71.3% | -35.0% | 27.7% | -14.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
81.6%
EPS terminal req.
$29.28
Spread vs growth
-42.3%
5Y implied EPS CAGR
48.6%
EPS terminal req.
$35.43
Spread vs growth
-9.3%
10Y implied EPS CAGR
27.9%
EPS terminal req.
$57.06
Spread vs growth
11.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+110.1%
Start / end P/E
44.7x → 67.5x
EPS bridge
3.51 → 4.89
Residual
+20.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.